EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease

Ignatios Ikonomidis, Konstantinos Katogiannis iD, Christina Chania, Nikolaos Iakovis, Maria Tsoumani, Andriana Christodoulou, Evangelia Brinia, George Pavlidis, John Thymis, Damianos Tsilivarakis, Aikaterini Kountouri, Emmanouil Korakas und 6 weitere

European Journal of Clinical Investigation · 2023-07 · 53 (7)

DOI: 10.1111/eci.13983 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 24.03.2023. Verfasst von Ignatios Ikonomidis und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Echocardiography and Preventive Cardiology, Second Cardiology Department, Attikon University Hospital, National and Kapodistrian Univer…. Hauptthemen laut MEDLINE: Heart Diseases, Coronary Disease. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Olive Heart Operational Programme Competitiveness, Entrepreneurship and Innovation 2014-2020 (EPAnEK).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hydroxytyrosol reduces low‐density lipoprotein oxidation, contributing to prevention of atherosclerosis progression.

Methods

In a prospective, crossover, double‐blind, placebo‐controlled trial, 30 chronic coronary artery syndrome (CCAS) patients were randomized to 4 capsules/day, containing 412.5 mg olive oil with 2.5 mg hydroxytyrosol (OOHT) each one or placebo for 1 month and then were crossed over to the alternate treatment (placebo or OOHT). We measured (a) perfused boundary region (PBR) of the sublingual arterial microvessels (increased PBR indicates reduced glycocalyx thickness), (b) flow‐mediated dilation (FMD), (c) Coronary Flow Reserve (CFR) and markers of LV diastolic function by Doppler echocardiography, (d) pulse wave velocity (PWV), and (e) oxidative stress, inflammatory biomarkers and blood lipids at baseline and after treatment.

Results

Treatment with OOHT improved PBR, FMD, CFR and PWV compared to baseline (1.8 ± .3 vs. 1.7 ± .4 μm, p = .040, 3.7 ± 2.1 vs. 6.5% ± 2.3%, p < .001, 2.3 ± .4 vs. 2.5 ± .4, p = .030 and 11.1 ± 1.8 vs. 11.8 ± 2.3 m/s, p = .002) while there was no effect after placebo ( p = NS). No effect of OOHT treatment was observed on blood pressure. There was a parallel improvement of E' of the mitral annulus and deceleration time of the E wave of mitral inflow after OOHT ( p < .05) but not after placebo. Compared to baseline, treatment with OOHT reduced malondialdehyde, a marker of lipid peroxidation, oxidized LDL, triglycerides, PCSK9 and CRP blood levels ( p < .05) in contrast to placebo.

Conclusions

Hydroxytyrosol‐enriched olive oil may have beneficial effects on endothelial, arterial and LV diastolic function likely by reducing oxidative and inflammatory burden in CCAS, though further studies are needed to confirm this mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart DiseasesCoronary DiseaseHumansProprotein Convertase 9Olive OilPulse Wave AnalysisProspective StudiesPhenylethyl Alcohol

Stichwörter der Autor:innen

Hydroxytyrosolcoronary flow reserveendothelial functionflow-mediated dilationoxidative stresspulse wave velocity

Substanzen

Proprotein Convertase 9Olive OilPCSK9 protein, human3,4-dihydroxyphenylethanolPhenylethyl Alcohol

Autor:innen und Institutionen

  • Laboratory of Echocardiography and Preventive Cardiology, Second Cardiology Department, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Cardiology, University Hospital of Larissa, Larissa, Greece.
  • Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Division of Pharmacognosy and Natural Products Chemistry, School of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
  • Intermed, Athens, Greece.

ORCID-Profile: Konstantinos Katogiannis

Förderung

  • Olive Heart Operational Programme Competitiveness, Entrepreneurship and Innovation 2014-2020 (EPAnEK)

Zitieren

APA

Ikonomidis, I., Katogiannis, K., Chania, C., Iakovis, N., Tsoumani, M., Christodoulou, A., Brinia, E., Pavlidis, G., Thymis, J., Tsilivarakis, D., Kountouri, A., Korakas, E., Lambadiari, V., Triposkiadis, F., Skaltsounis, L., Tseti, I., Iliodromitis, E. K., & Andreadou, I. (2023). Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease. European Journal of Clinical Investigation, 53(7). https://doi.org/10.1111/eci.13983

Vancouver

Ikonomidis I, Katogiannis K, Chania C, Iakovis N, Tsoumani M, Christodoulou A, et al. Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease. European Journal of Clinical Investigation. 2023;53(7). doi:10.1111/eci.13983

BibTeX
@article{Ikonomidis2023,
  author = {Ikonomidis, Ignatios and Katogiannis, Konstantinos and Chania, Christina and Iakovis, Nikolaos and Tsoumani, Maria and Christodoulou, Andriana and Brinia, Evangelia and Pavlidis, George and Thymis, John and Tsilivarakis, Damianos and Kountouri, Aikaterini and Korakas, Emmanouil and Lambadiari, Vaia and Triposkiadis, Filippos and Skaltsounis, Leandros and Tseti, Ioulia and Iliodromitis, Efstathios K and Andreadou, Ioanna},
  title = {Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease},
  journal = {European Journal of Clinical Investigation},
  year = {2023},
  volume = {53},
  number = {7},
  doi = {10.1111/eci.13983}
}
Kostenlos starten →